Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.18 [1.08-1.29],0.000398877906455522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,0.85 [0.76-0.94],0.00185588653348001,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,0.33 [0.16-0.67],0.00224773785676039,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.33 [0.16-0.68],0.00278219274358502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.23 [1.07-1.41],0.00298748945246337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.79 [0.68-0.93],0.00348670223433352,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1.39 [1.12-1.74],0.00349563876974544,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LGALS4,Galectin-4,Inverse variance weighted,4,1.39 [1.11-1.72],0.00353504434600965,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.29 [0.12-0.69],0.00528280559894992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,20,1.08 [1.02-1.15],0.00561190418972119,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.76 [0.62-0.93],0.00686468515917881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.2 [1.05-1.37],0.00770941874883191,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCG2,Secretogranin-2,Wald ratio,1,0.37 [0.17-0.79],0.010087999569546,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,APOA4,Apolipoprotein A-IV,Wald ratio,1,0.36 [0.16-0.79],0.010456551888023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.23 [1.04-1.44],0.0127912157125371,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CTRB1,Chymotrypsinogen B,Inverse variance weighted,27,0.92 [0.86-0.98],0.0130691827321334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.92 [0.87-0.98],0.0138981674232954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.6 [1.09-2.34],0.0152337709734615,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.07 [1.01-1.13],0.0185414367126474,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,0.91 [0.84-0.99],0.0195701562110503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,1.16 [1.02-1.31],0.020389706818665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VCAN,Versican core protein,Inverse variance weighted,31,0.93 [0.88-0.99],0.0228748454438815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DRAXIN,Draxin,Inverse variance weighted,13,1.09 [1.01-1.18],0.0229326754750018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.89 [0.8-0.99],0.0257840597100098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.53 [0.3-0.94],0.0289325550773727,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.08 [1.01-1.16],0.0315131754742795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,1.09 [1.01-1.18],0.0318869225792928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.12 [1.01-1.24],0.0324208788541663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.92 [0.85-0.99],0.0327834224014289,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.86 [0.76-0.99],0.0328675848134454,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,1.33 [1.02-1.74],0.0349024708927083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.23 [1.01-1.5],0.035395815476278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CTSL,Cathepsin L1,Wald ratio,1,2.31 [1.06-5.03],0.0354305376985684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NUCB2,Nucleobindin-2,Inverse variance weighted,24,0.91 [0.84-0.99],0.0356046255775522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LGALS9,Galectin-9,Inverse variance weighted,26,1.08 [1-1.17],0.0377727296168368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.91 [0.82-1],0.0390216436989818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.93 [0.86-1],0.0395398618848099,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GHRL,Appetite-regulating hormone,Inverse variance weighted,3,0.93 [0.86-1],0.0440918946473023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,5,0.8 [0.65-1],0.0448380202068563,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,0.92 [0.85-1],0.0518280917810487,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.86 [0.74-1],0.0521301134897909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.05 [1-1.11],0.0547483733378145,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDH15,Cadherin-15,Inverse variance weighted,18,0.92 [0.84-1],0.058296049771027,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.09 [1-1.19],0.0595399116898661,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.06 [1-1.13],0.0639089134797235,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,0.85 [0.71-1.01],0.0646345422669559,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.19 [0.99-1.45],0.0694353102131001,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.12 [0.99-1.26],0.0712321587984644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,0.89 [0.78-1.01],0.0712876433608704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.76 [0.56-1.03],0.0749991213718057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.35 [0.97-1.89],0.0795146992877683,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.67 [0.42-1.06],0.0847591943287622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.03 [1-1.07],0.0847667222381129,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,16,0.91 [0.83-1.01],0.0857890354846979,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.12 [0.98-1.28],0.0863994933851125,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RGMB,RGM domain family member B,Inverse variance weighted,9,0.88 [0.75-1.02],0.0874804889788042,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.93 [0.85-1.01],0.0890725495433978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.93 [0.89-4.22],0.0973641974628117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,XCL1,Lymphotactin,Inverse variance weighted,31,0.95 [0.9-1.01],0.0975748657316526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.21 [0.96-1.51],0.0997526725931731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.11 [0.98-1.24],0.0997555745660755,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.93 [0.84-1.02],0.10492492308596,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.93 [0.85-1.02],0.111421202604832,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LCN15,Lipocalin-15,Inverse variance weighted,20,1.05 [0.99-1.12],0.120469807475632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Inverse variance weighted,6,0.89 [0.76-1.03],0.12698996181861,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.24 [0.93-1.66],0.134388486226895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,1.16 [0.95-1.41],0.136893880032405,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.92 [0.82-1.03],0.137717923637579,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.93 [0.84-1.03],0.139868049028193,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.7 [0.44-1.13],0.144023973281577,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AREG,Amphiregulin,Inverse variance weighted,3,0.84 [0.67-1.06],0.152999473972532,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.94 [0.87-1.02],0.153455726053769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.09 [0.97-1.23],0.153565958599828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PRSS2,Trypsin-2,Inverse variance weighted,3,1.18 [0.94-1.48],0.156888381136153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,3,0.83 [0.64-1.08],0.159595871327361,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD46,Membrane cofactor protein,Wald ratio,1,0.75 [0.5-1.12],0.159833542340233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.85 [0.67-1.07],0.162144822117678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.96 [0.9-1.02],0.162900983196838,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VIT,Vitrin,Inverse variance weighted,25,0.96 [0.91-1.02],0.170007639602861,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL19,Interleukin-19,Inverse variance weighted,11,1.08 [0.97-1.2],0.171633293872359,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NRP2,Neuropilin-2,Inverse variance weighted,11,0.92 [0.81-1.04],0.174144614472873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.84 [0.66-1.08],0.174677225835672,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.07 [0.97-1.19],0.176726404727966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,40,1.04 [0.98-1.09],0.179269813665393,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.91 [0.79-1.05],0.180761894404599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RETN,Resistin,Inverse variance weighted,9,0.95 [0.88-1.02],0.182149710180982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.16 [0.93-1.43],0.183200448683464,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,1.22 [0.91-1.65],0.18580604390424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1.04 [0.98-1.1],0.18789662831892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CALB2,Calretinin,Wald ratio,1,1.48 [0.82-2.64],0.191069661606181,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,0.85 [0.67-1.08],0.191075336773792,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,0.86 [0.69-1.08],0.193781602565163,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.12 [0.94-1.33],0.194141763323127,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLK11,Kallikrein-11,Inverse variance weighted,6,0.95 [0.88-1.03],0.196201644025752,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.07 [0.96-1.19],0.205625384171788,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.93 [0.84-1.04],0.206025581986858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDH3,Cadherin-3,Inverse variance weighted,2,1.3 [0.86-1.98],0.210797400495822,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RGMA,Repulsive guidance molecule A,Inverse variance weighted,12,0.94 [0.86-1.04],0.211391737740075,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.17 [0.91-1.49],0.212025024051574,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1.86 [0.7-4.98],0.213642802667544,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,0.84 [0.65-1.1],0.217260478492453,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.91 [0.78-1.06],0.219116081757071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.09 [0.95-1.25],0.220741520863056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VWC2,Brorin,Inverse variance weighted,22,1.07 [0.96-1.2],0.221935503932271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.12 [0.93-1.34],0.226346160781502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PRSS8,Prostasin,Inverse variance weighted,5,0.86 [0.67-1.1],0.226745644883079,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LAYN,Layilin,Inverse variance weighted,20,1.07 [0.96-1.18],0.22752198746344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.88 [0.71-1.09],0.228333188445459,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.18 [0.9-1.56],0.231167934866072,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.3 [0.84-2.02],0.236322114808831,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,1.05 [0.97-1.13],0.238077984173493,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,0.92 [0.8-1.06],0.240341662805977,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.82 [0.59-1.14],0.241578294183632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPON1,Spondin-1,Inverse variance weighted,21,1.05 [0.96-1.15],0.247467425262325,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.93 [0.82-1.05],0.250244340530325,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NECTIN4,Nectin-4,Inverse variance weighted,7,1.06 [0.96-1.18],0.25903514634398,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD7,T-cell antigen CD7,Inverse variance weighted,8,0.96 [0.89-1.03],0.269620500695815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PALM2,Paralemmin-2,Inverse variance weighted,8,1.08 [0.94-1.25],0.269662390420252,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FAM3D,Protein FAM3D,Inverse variance weighted,17,1.08 [0.94-1.25],0.270528926878772,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.04 [0.97-1.11],0.278928565317813,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,1.05 [0.96-1.16],0.281784526873201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.92 [0.78-1.07],0.282274358954438,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.89 [0.72-1.1],0.285702214920528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.79 [0.52-1.21],0.286102485647521,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,14,1.06 [0.96-1.17],0.288531942900874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,0.96 [0.89-1.04],0.289509326615222,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.93 [0.81-1.07],0.290977584660509,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,1.02 [0.98-1.07],0.292977967537871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1.23 [0.83-1.82],0.293444895713147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLK6,Kallikrein-6,Inverse variance weighted,4,1.1 [0.92-1.31],0.295298911449711,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AGRN,Agrin,Inverse variance weighted,17,0.94 [0.85-1.05],0.296418963801457,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.06 [0.95-1.17],0.296776781572139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLK4,Kallikrein-4,Inverse variance weighted,17,1.04 [0.96-1.12],0.299758273406817,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.13 [0.9-1.42],0.300736809574735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.95 [0.86-1.05],0.301892610818837,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.34 [0.77-2.33],0.303779881858858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.03 [0.97-1.09],0.30542607738714,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,0.95 [0.86-1.05],0.308143290488228,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,1.35 [0.75-2.41],0.31146259652321,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,REN,Renin,Inverse variance weighted,4,1.07 [0.94-1.21],0.315436886623175,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,1.08 [0.93-1.24],0.315696257383851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,0.98 [0.93-1.02],0.316996932314384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ANXA5,Annexin A5,Inverse variance weighted,2,1.24 [0.81-1.89],0.31861125173168,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,0.97 [0.92-1.03],0.324299744326831,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RTBDN,Retbindin,Inverse variance weighted,3,0.87 [0.66-1.15],0.327607630144344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,21,1.05 [0.95-1.15],0.330998994954817,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.79 [0.49-1.27],0.331279863986993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,3,1.15 [0.86-1.54],0.335007271540599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,COL1A1,Collagen alpha-1(I) chain,Wald ratio,1,1.47 [0.67-3.22],0.3380554748631,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PALM,Paralemmin-1,Inverse variance weighted,6,0.92 [0.77-1.1],0.342065396777982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SEPTIN8,Septin-8,Inverse variance weighted,2,0.77 [0.46-1.31],0.343351667606385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,1.05 [0.95-1.17],0.343369250210831,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CST6,Cystatin-M,Inverse variance weighted,2,1.09 [0.91-1.3],0.343613413786823,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1.04 [0.96-1.13],0.346638039561512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDHR1,Cadherin-related family member 1,Inverse variance weighted,9,1.05 [0.95-1.17],0.35010857288575,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MMP10,Stromelysin-2,Inverse variance weighted,22,1.04 [0.96-1.13],0.351960670897462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CTSV,Cathepsin L2,Inverse variance weighted,11,0.94 [0.83-1.07],0.354675782272623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.97 [0.92-1.03],0.358483127232006,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CALCA,Calcitonin,Inverse variance weighted,5,1.16 [0.84-1.62],0.361866302389543,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CFD,Complement factor D,Inverse variance weighted,11,0.95 [0.85-1.06],0.363760711962402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.02 [0.97-1.08],0.364382998738178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SDC1,Syndecan-1,Inverse variance weighted,2,1.18 [0.82-1.7],0.364426751644465,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AGRP,Agouti-related protein,Inverse variance weighted,3,1.26 [0.77-2.06],0.364552307981519,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.05 [0.95-1.17],0.364561095255296,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.94 [0.83-1.07],0.364926652105668,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,COLEC12,Collectin-12,Inverse variance weighted,11,0.94 [0.82-1.08],0.367092753396749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.97 [0.91-1.03],0.367851212465535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1.02 [0.98-1.06],0.369588779839259,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.97 [0.91-1.03],0.375077832117683,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GP1BA,Platelet glycoprotein Ib alpha chain,Inverse variance weighted,2,1.17 [0.83-1.64],0.376020121114852,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.05 [0.95-1.16],0.390052313316285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SEZ6L,Seizure 6-like protein,Inverse variance weighted,8,0.94 [0.83-1.08],0.393848970587771,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BSG,Basigin,Wald ratio,1,0.89 [0.69-1.16],0.394258013241093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.11 [0.88-1.4],0.394454365837747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PGA4,Pepsin A-4,Inverse variance weighted,2,1.24 [0.75-2.05],0.395142116967787,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CST3,Cystatin-C,Inverse variance weighted,10,1.05 [0.94-1.18],0.395766271541764,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,21,0.98 [0.95-1.02],0.399191294260002,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.88 [0.66-1.18],0.39939273189957,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.95 [0.83-1.08],0.403364377668069,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,0.98 [0.93-1.03],0.405422390366084,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.93 [0.77-1.11],0.406087424298235,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VASN,Vasorin,Inverse variance weighted,14,1.03 [0.96-1.1],0.406153181568842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PI3,Elafin,Inverse variance weighted,10,1.05 [0.94-1.16],0.41272810834657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.79 [0.44-1.42],0.425844884593165,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,6,1.07 [0.91-1.26],0.431733937268064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.05 [0.93-1.18],0.432366031463945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,6,0.94 [0.8-1.1],0.4340095332307,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,0.96 [0.85-1.07],0.435838889455506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NPPC,C-type natriuretic peptide,Wald ratio,1,1.41 [0.59-3.32],0.437730456900111,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDH1,Cadherin-1,Wald ratio,1,0.74 [0.34-1.6],0.44099981641555,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.9 [0.69-1.18],0.441861196419412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,0.95 [0.84-1.08],0.442443926389973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,1.03 [0.96-1.1],0.444871139776808,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,11,1.06 [0.91-1.24],0.447316719032107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.9 [0.69-1.18],0.448352954771388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PLIN3,Perilipin-3,Wald ratio,1,1.21 [0.74-1.98],0.454289843838381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.94 [0.79-1.11],0.455979932770593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GPR158,Probable G-protein coupled receptor 158,Wald ratio,1,0.81 [0.46-1.42],0.456132841474159,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,0.92 [0.74-1.14],0.461185627065205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.91 [0.71-1.17],0.462281383483882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHAD,Chondroadherin,Inverse variance weighted,3,1.04 [0.93-1.17],0.464334165204633,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DLK1,Protein delta homolog 1,Inverse variance weighted,25,1.02 [0.96-1.09],0.464348098130541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDH6,Cadherin-6,Inverse variance weighted,29,1.02 [0.96-1.09],0.466020594238233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.92 [0.72-1.16],0.466440164830702,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PRELP,Prolargin,Inverse variance weighted,9,1.04 [0.93-1.16],0.46889121815993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FAM3B,Protein FAM3B,Inverse variance weighted,18,0.98 [0.92-1.04],0.470333275389995,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,OCLN,Occludin,Inverse variance weighted,2,0.9 [0.69-1.19],0.471343193997795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LGALS3,Galectin-3,Inverse variance weighted,25,1.03 [0.95-1.11],0.480238889099268,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.13 [0.8-1.58],0.484543770326646,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EDN1,Endothelin-1,Inverse variance weighted,3,1.1 [0.84-1.45],0.493750342658703,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.95 [0.81-1.11],0.49551621809714,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,1.04 [0.94-1.14],0.496574057307616,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.06 [0.9-1.25],0.49664184864575,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TMSB10,Thymosin beta-10,Wald ratio,1,1.24 [0.67-2.29],0.499310553376692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.09 [0.85-1.39],0.500603918268587,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PCDHB15,Protocadherin beta-15,Inverse variance weighted,29,1.02 [0.97-1.07],0.500659652400096,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.95 [0.8-1.12],0.507614532810466,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.98 [0.92-1.04],0.507692224183556,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD302,CD302 antigen,Inverse variance weighted,9,0.96 [0.85-1.08],0.510966331000953,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,F3,Tissue factor,Inverse variance weighted,11,1.05 [0.92-1.19],0.511210747054242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,1.09 [0.84-1.42],0.514200889835855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MMP3,Stromelysin-1,Inverse variance weighted,34,1.03 [0.94-1.12],0.514376498922709,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLRF1,Killer cell lectin-like receptor subfamily F member 1,Inverse variance weighted,2,1.19 [0.71-1.99],0.514913697318487,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MB,Myoglobin,Wald ratio,1,1.37 [0.53-3.54],0.520593609348506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.93 [0.76-1.15],0.520619191580285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,2,0.85 [0.53-1.38],0.52219347718786,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.75 [0.31-1.83],0.525106406806927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LMNB2,Lamin-B2,Wald ratio,1,0.75 [0.31-1.82],0.526263117874856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,1.07 [0.86-1.33],0.528507228963152,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.09 [0.83-1.43],0.530823878207543,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PSAP,Prosaposin,Inverse variance weighted,5,1.06 [0.88-1.27],0.531108808118459,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL17C,Interleukin-17C,Inverse variance weighted,3,0.89 [0.61-1.29],0.531511715233604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,0.89 [0.6-1.3],0.533081373739057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.88 [0.59-1.31],0.534518962692359,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1.04 [0.93-1.16],0.537528632790674,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.12 [0.78-1.63],0.537619285783378,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPRR3,Small proline-rich protein 3,Inverse variance weighted,11,1.05 [0.91-1.2],0.53830130242113,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CX3CL1,Fractalkine,Inverse variance weighted,9,0.95 [0.8-1.12],0.538502657112808,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.96 [0.84-1.1],0.539051369072473,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SERPINB8,Serpin B8,Inverse variance weighted,28,0.99 [0.95-1.03],0.539923642585769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.92 [0.7-1.2],0.540693699472293,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.96 [0.85-1.09],0.543081442749899,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.97 [0.87-1.08],0.54311138637961,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CALB1,Calbindin,Inverse variance weighted,2,0.88 [0.58-1.33],0.547556765446041,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,7,1.08 [0.85-1.36],0.547584255762723,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NXPH3,Neurexophilin-3,Inverse variance weighted,11,0.97 [0.86-1.08],0.548723858707301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.98 [0.91-1.05],0.551205476492799,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.03 [0.94-1.12],0.551339377654979,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.03 [0.93-1.14],0.552999047310595,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.08 [0.83-1.41],0.553709702636198,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PENK,Proenkephalin-A,Inverse variance weighted,19,1.03 [0.94-1.13],0.554072987884893,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,0.97 [0.89-1.07],0.555369149369493,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DSG3,Desmoglein-3,Inverse variance weighted,7,1.04 [0.91-1.19],0.558000422723962,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.14 [0.74-1.76],0.561121157468301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD160,CD160 antigen,Inverse variance weighted,11,0.97 [0.88-1.07],0.56128020210087,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.02 [0.95-1.1],0.569673636342779,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PLA2G1B,Phospholipase A2,Wald ratio,1,0.84 [0.45-1.56],0.57302067737546,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.25 [0.58-2.71],0.57334559655752,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.97 [0.88-1.07],0.574878084689975,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NECTIN2,Nectin-2,Inverse variance weighted,5,0.97 [0.88-1.08],0.575733391067324,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,1.08 [0.83-1.41],0.577013446296385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.26 [0.55-2.89],0.578937923767267,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RBP2,Retinol-binding protein 2,Wald ratio,1,0.85 [0.47-1.53],0.580864290065448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.92 [0.68-1.24],0.580991619716492,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCN5,CCN family member 5,Inverse variance weighted,8,0.91 [0.66-1.26],0.58158992926555,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.01 [0.97-1.05],0.583516856234409,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.02 [0.96-1.08],0.585205788475007,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.33 [0.48-3.67],0.585752940479998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,1.04 [0.89-1.22],0.589830271263683,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,14,0.97 [0.89-1.07],0.591810969067602,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL15,Interleukin-15,Wald ratio,1,2.47 [0.09-67.12],0.591867927204023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,5,1.1 [0.77-1.59],0.592854753932811,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,10,1.03 [0.91-1.17],0.592951265333203,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.08 [0.81-1.46],0.593596701375221,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.92 [0.68-1.25],0.594585128943258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.04 [0.9-1.21],0.594683532849937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GRN,Progranulin,Inverse variance weighted,7,0.96 [0.82-1.12],0.59644457039931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Wald ratio,1,1.03 [0.92-1.16],0.600555478146266,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.03 [0.92-1.16],0.60167036537572,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RSPO3,R-spondin-3,Inverse variance weighted,6,0.94 [0.73-1.2],0.606611967094125,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,UMOD,Uromodulin,Inverse variance weighted,29,1.01 [0.97-1.06],0.606613763038988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,21,0.98 [0.9-1.06],0.610761610294708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,1.06 [0.85-1.33],0.611009643139943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.22 [0.56-2.64],0.612741705211657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.03 [0.92-1.15],0.614319444333621,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,THBD,Thrombomodulin,Inverse variance weighted,5,1.04 [0.88-1.24],0.619887538612833,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RNASE6,Ribonuclease K6,Inverse variance weighted,15,0.98 [0.92-1.05],0.620718856724127,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,0.96 [0.82-1.13],0.622670260989442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,0.85 [0.44-1.64],0.628556673003581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.98 [0.9-1.07],0.633060033806081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.89 [0.53-1.47],0.638543897801726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.9 [0.57-1.42],0.643971189277948,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.98 [0.91-1.06],0.644256053613584,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DSC2,Desmocollin-2,Inverse variance weighted,9,0.97 [0.86-1.1],0.645510513371017,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.05 [0.85-1.29],0.652276249433453,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,0.99 [0.94-1.04],0.652877300909452,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.02 [0.94-1.1],0.654999588528246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,9,0.97 [0.86-1.1],0.656175362105472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ALCAM,CD166 antigen,Inverse variance weighted,6,0.95 [0.76-1.19],0.658629773472187,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AMBP,Protein AMBP,Inverse variance weighted,3,1.05 [0.83-1.34],0.660312766971498,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.08 [0.77-1.5],0.662869489623568,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.03 [0.91-1.16],0.663263375632716,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.06 [0.82-1.37],0.663966523998373,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.02 [0.94-1.09],0.670952321886781,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.92 [0.62-1.36],0.671513902382788,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,0.98 [0.91-1.06],0.673559611429708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,APOA2,Apolipoprotein A-II,Wald ratio,1,0.89 [0.52-1.53],0.676532055838433,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.97 [0.83-1.13],0.676802526070642,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.08 [0.74-1.59],0.67921647002668,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KITLG,Kit ligand,Wald ratio,1,1.16 [0.57-2.34],0.687281628237708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,0.95 [0.74-1.22],0.688148035311388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.98 [0.86-1.11],0.703591676596292,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,0.96 [0.8-1.16],0.70366894473638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHGA,Chromogranin-A,Inverse variance weighted,3,1.04 [0.86-1.24],0.706830846222442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.84 [0.33-2.13],0.713271256738024,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,24,1.01 [0.96-1.07],0.718471071559353,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,1.01 [0.96-1.07],0.718677981186299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PGF,Placenta growth factor,Inverse variance weighted,2,0.85 [0.34-2.11],0.718716430504965,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.98 [0.88-1.09],0.719737879125457,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.02 [0.91-1.15],0.721688845666621,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.95 [0.69-1.3],0.729086221338871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD83,CD83 antigen,Inverse variance weighted,5,0.96 [0.76-1.21],0.732011475530939,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,12,0.98 [0.85-1.12],0.738292704620128,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MMP7,Matrilysin,Inverse variance weighted,13,1.02 [0.91-1.14],0.740926458944532,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,OGN,Mimecan,Inverse variance weighted,30,0.98 [0.9-1.08],0.744112835203218,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.98 [0.86-1.12],0.744855036801225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.07 [0.72-1.59],0.749223662111411,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NRP1,Neuropilin-1,Inverse variance weighted,12,0.98 [0.89-1.09],0.749402160401952,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,0.99 [0.94-1.05],0.756077418138896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.02 [0.88-1.2],0.757923361812915,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FBLN2,Fibulin-2,Inverse variance weighted,11,0.99 [0.9-1.08],0.761681910924702,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NEO1,Neogenin,Wald ratio,1,0.93 [0.58-1.49],0.765598759423419,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.99 [0.92-1.06],0.765861251446141,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.97 [0.82-1.16],0.766003815484725,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DSG2,Desmoglein-2,Inverse variance weighted,11,0.98 [0.87-1.11],0.767998356192111,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,1.04 [0.81-1.33],0.769992769096727,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.95 [0.69-1.31],0.772334633678753,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.11 [0.55-2.21],0.774398367633793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,1.04 [0.78-1.39],0.775720322559371,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.98 [0.83-1.15],0.777615580248386,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DPT,Dermatopontin,Inverse variance weighted,21,0.99 [0.9-1.08],0.79023021806585,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.99 [0.89-1.09],0.791283229027098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,50,1.01 [0.97-1.05],0.793226564140797,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,18,0.99 [0.9-1.08],0.794021205218073,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.04 [0.75-1.45],0.796299794913001,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCN4,CCN family member 4,Inverse variance weighted,27,1.01 [0.94-1.08],0.797729084485038,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCGB1A1,Uteroglobin,Inverse variance weighted,12,1.01 [0.91-1.12],0.797817323926146,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.94 [0.56-1.56],0.798917092204671,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.05 [0.74-1.48],0.799329699410548,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BGLAP,Osteocalcin,Inverse variance weighted,2,1.07 [0.64-1.77],0.79974265830318,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,0.99 [0.88-1.11],0.801696400509383,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLK8,Kallikrein-8,Inverse variance weighted,12,1.01 [0.92-1.12],0.803642090749925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.02 [0.87-1.2],0.806444383643769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,1.02 [0.89-1.16],0.806676831712003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.01 [0.92-1.12],0.807962728314634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.01 [0.95-1.07],0.808358312509322,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.99 [0.93-1.06],0.814596517763208,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CTSZ,Cathepsin Z,Inverse variance weighted,3,1.02 [0.88-1.17],0.818278745958174,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1.02 [0.88-1.17],0.822889463895829,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.01 [0.92-1.11],0.824622397004489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHGB,Secretogranin-1,Inverse variance weighted,27,1.01 [0.95-1.07],0.824739598527311,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VGF,Neurosecretory protein VGF,Wald ratio,1,0.89 [0.33-2.39],0.824854674603357,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.05 [0.68-1.61],0.827706164703555,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPARCL1,SPARC-like protein 1,Inverse variance weighted,35,1.01 [0.95-1.07],0.831037351462696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.04 [0.72-1.51],0.831982631657014,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1 [0.96-1.05],0.832573008488099,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.95 [0.6-1.51],0.833751933539013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CSTB,Cystatin-B,Inverse variance weighted,28,1.01 [0.94-1.09],0.834427691580625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.02 [0.82-1.28],0.834668138023207,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,22,1.01 [0.95-1.07],0.837270757334703,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.02 [0.83-1.25],0.840687791353955,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.96 [0.62-1.47],0.844898209348784,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,30,1 [0.96-1.04],0.844982217171707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.01 [0.94-1.08],0.853008349405078,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.06 [0.56-2.01],0.855467894934107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.03 [0.75-1.42],0.85770041215851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.99 [0.89-1.1],0.859076555226881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.98 [0.8-1.21],0.865704349110428,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RSPO1,R-spondin-1,Inverse variance weighted,5,0.98 [0.79-1.22],0.86625414124919,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1 [0.96-1.06],0.867070560098321,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,0.98 [0.78-1.24],0.867207281330346,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,4,0.97 [0.67-1.4],0.868439189551431,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.02 [0.77-1.36],0.870758148547104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1 [0.96-1.05],0.87224708614597,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,0.98 [0.77-1.25],0.872721587933292,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FABP6,Gastrotropin,Wald ratio,1,0.98 [0.75-1.28],0.876041967415567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1.01 [0.94-1.07],0.881230242060759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1 [0.96-1.05],0.882286781211557,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.99 [0.92-1.07],0.884774049201825,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,0.99 [0.84-1.17],0.885870743415352,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ANG,Angiogenin,Inverse variance weighted,19,1.01 [0.93-1.09],0.887119698054303,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1 [0.95-1.05],0.889333296126869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPON2,Spondin-2,Inverse variance weighted,4,1.01 [0.87-1.18],0.889890904577983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.01 [0.92-1.1],0.891836852302453,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.94 [0.41-2.2],0.893614567802083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,UNC5D,Netrin receptor UNC5D,Wald ratio,1,1.21 [0.06-23.18],0.897601364430578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,14,1.01 [0.9-1.12],0.899752900054273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.01 [0.83-1.23],0.903374226590604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MDK,Midkine,Inverse variance weighted,4,1.02 [0.69-1.52],0.904078701915037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PCDH12,Protocadherin-12,Inverse variance weighted,13,1.01 [0.92-1.1],0.904892335191315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.04 [0.55-1.97],0.906103444712853,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,1 [0.92-1.08],0.90766844337467,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1.01 [0.9-1.12],0.908151578159381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,0.95 [0.42-2.19],0.910119511143025,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,1 [0.95-1.06],0.912002061235945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.01 [0.91-1.12],0.918286957401523,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,3,0.98 [0.68-1.41],0.921130637100912,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCN3,CCN family member 3,Inverse variance weighted,19,1.01 [0.9-1.12],0.923420061147198,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.99 [0.8-1.23],0.925556968459447,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1 [0.94-1.07],0.926823741212194,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.01 [0.79-1.29],0.929402158399335,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPP1,Osteopontin,Inverse variance weighted,8,0.99 [0.74-1.32],0.929419647820808,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GUCA2A,Guanylin,Inverse variance weighted,9,1.01 [0.86-1.18],0.941696958632444,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,1 [0.92-1.08],0.943474013537793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,22,1 [0.9-1.1],0.94860850029785,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,1.02 [0.57-1.83],0.953238884647079,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.01 [0.79-1.28],0.957468466965771,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.01 [0.79-1.28],0.957987711720379,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,1.01 [0.81-1.25],0.960373104311808,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LGALS1,Galectin-1,Inverse variance weighted,6,1 [0.9-1.11],0.96350155022454,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,0.99 [0.6-1.64],0.969347403556786,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1 [0.92-1.08],0.970101271450561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1 [0.82-1.21],0.971367320901469,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD27,CD27 antigen,Inverse variance weighted,9,1 [0.9-1.11],0.972750672065857,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1 [0.79-1.25],0.976041035449868,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1 [0.88-1.15],0.983029423660191,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1 [0.89-1.12],0.984048252964262,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1 [0.9-1.11],0.986438485988116,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MMP13,Collagenase 3,Inverse variance weighted,2,0.99 [0.42-2.34],0.987591530017692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1 [0.93-1.08],0.988925480245568,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MXRA8,Matrix remodeling-associated protein 8,Wald ratio,1,1 [0.61-1.63],0.992975011534795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.33 [0.16-0.68],0.00278219274358502,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PGF,Placenta growth factor,Inverse variance weighted,5,0.67 [0.51-0.88],0.00426988392300945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,0.91 [0.85-0.98],0.00802379818867803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,0.74 [0.59-0.93],0.008783380685566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,0.8 [0.67-0.95],0.0122889763541561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LGALS9,Galectin-9,Inverse variance weighted,36,1.1 [1.02-1.18],0.0137989204556041,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.63 [0.43-0.92],0.0174785445780266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.68 [0.49-0.94],0.0188524550758402,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTH,Parathyroid hormone,Inverse variance weighted,11,1.25 [1.04-1.5],0.0191274362347647,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.6 [0.38-0.93],0.0225255533203175,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CST6,Cystatin-M,Inverse variance weighted,26,1.18 [1.02-1.37],0.0258067538587334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,0.75 [0.58-0.97],0.0276938126843849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.25 [1.02-1.53],0.032319272115151,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,24,0.84 [0.72-0.99],0.0333025018173586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.19 [1.01-1.4],0.0353745017965218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.13 [1.01-1.26],0.0353932181824927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.73 [0.54-0.98],0.0381342274810239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDH6,Cadherin-6,Inverse variance weighted,5,1.53 [1.02-2.3],0.039537823444506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,1.13 [1-1.26],0.0409613655651536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,1.07 [1-1.15],0.0418507970597112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,1.04 [1-1.09],0.0425670894380106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,0.84 [0.71-1],0.0455051924652631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.16 [1-1.34],0.0510869404916176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.11 [1-1.25],0.0582114276427412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KITLG,Kit ligand,Inverse variance weighted,30,1.14 [0.99-1.3],0.0627795243397322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.31 [0.98-1.75],0.066056545951895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.13 [0.99-1.29],0.0684023610009197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GDF15,Growth/differentiation factor 15,Wald ratio,1,2.65 [0.93-7.6],0.068950972054278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,17,0.86 [0.73-1.01],0.0707353911055322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.54 [0.96-2.46],0.0727085226171132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,1.83 [0.94-3.55],0.0743178748943776,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.66 [0.42-1.04],0.0753195523700142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1.23 [0.98-1.54],0.0754207528782555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,2,1.49 [0.96-2.32],0.0775626120153397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.34 [0.97-1.86],0.0776071239336749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,2.22 [0.9-5.45],0.0817069454837542,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PSAP,Prosaposin,Inverse variance weighted,13,1.11 [0.99-1.25],0.0822135396978745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AGRN,Agrin,Inverse variance weighted,14,0.81 [0.63-1.03],0.0823779362655092,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.62 [0.36-1.06],0.0831916612298272,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1.08 [0.99-1.17],0.083351753036205,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,UMOD,Uromodulin,Inverse variance weighted,34,1.11 [0.99-1.25],0.0836734154532295,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.36 [0.96-1.93],0.0856217378890246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,COL1A1,Collagen alpha-1(I) chain,Inverse variance weighted,16,0.86 [0.73-1.02],0.0871203364442437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,22,1.13 [0.98-1.31],0.0875553833610952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.54 [0.94-2.53],0.0892086247435526,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DRAXIN,Draxin,Inverse variance weighted,25,1.13 [0.98-1.31],0.0964843330425587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.11 [0.98-1.26],0.102004064763826,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.76 [0.54-1.06],0.10595856492594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.62 [0.34-1.11],0.106102635292144,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,3,1.47 [0.92-2.35],0.109353474267286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MMP10,Stromelysin-2,Wald ratio,1,0.48 [0.19-1.18],0.11025973666584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,35,0.94 [0.87-1.01],0.11028131241302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,1.24 [0.95-1.61],0.114031515818548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,0.49 [0.2-1.2],0.116487453816892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MDK,Midkine,Inverse variance weighted,14,0.86 [0.71-1.04],0.119056782193484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LMNB2,Lamin-B2,Inverse variance weighted,8,1.24 [0.95-1.61],0.119623829128513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.23 [0.94-1.61],0.1278802347587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.12 [0.97-1.29],0.129438160429907,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FBLN2,Fibulin-2,Inverse variance weighted,6,1.26 [0.93-1.71],0.129641875014433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,0.81 [0.62-1.06],0.130078047263577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.24 [0.94-1.63],0.131791608222058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.9 [0.79-1.03],0.1329201122813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CYTL1,Cytokine-like protein 1,Inverse variance weighted,3,1.41 [0.9-2.22],0.13469733779579,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.48 [0.88-2.49],0.13641370020881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.96 [0.9-1.01],0.136465807731333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.72 [0.46-1.11],0.137224995718267,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1.16 [0.95-1.41],0.137364437450642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TCN2,Transcobalamin-2,Inverse variance weighted,24,1.06 [0.98-1.14],0.138650047539654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ACRV1,Acrosomal protein SP-10,Wald ratio,1,0.4 [0.12-1.35],0.140084644024233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.78 [0.56-1.09],0.146620064065987,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.28 [0.91-1.8],0.148886804619032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD302,CD302 antigen,Inverse variance weighted,11,1.13 [0.96-1.35],0.150806910523296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LCN15,Lipocalin-15,Inverse variance weighted,22,1.05 [0.98-1.11],0.151771930780049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.77 [0.54-1.1],0.157145265689763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.66 [0.38-1.17],0.157694273016026,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,1.63 [0.83-3.21],0.159358461323423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.2 [0.93-1.54],0.170209605630771,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD7,T-cell antigen CD7,Inverse variance weighted,12,0.95 [0.88-1.02],0.170511337585635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.16 [0.94-1.44],0.172995424734007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD99,CD99 antigen,Inverse variance weighted,4,0.82 [0.61-1.1],0.17816348079066,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CST3,Cystatin-C,Inverse variance weighted,3,1.46 [0.84-2.54],0.18124902743053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RGMB,RGM domain family member B,Inverse variance weighted,5,0.73 [0.45-1.16],0.183567605136214,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DLK1,Protein delta homolog 1,Inverse variance weighted,10,0.81 [0.59-1.11],0.184453482446736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.17 [0.93-1.47],0.191432937391903,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.07 [0.97-1.19],0.191923982470287,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.12 [0.94-1.33],0.194141763323127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PCDH12,Protocadherin-12,Inverse variance weighted,6,1.38 [0.85-2.23],0.195832370460965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.06 [0.97-1.16],0.205508597489776,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,1.13 [0.93-1.36],0.209136563465478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.62 [0.29-1.31],0.209587924873469,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLK6,Kallikrein-6,Inverse variance weighted,2,1.36 [0.84-2.2],0.211306222402359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.8 [0.57-1.14],0.213454705916569,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,43,0.98 [0.95-1.01],0.219537288400361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.88 [0.72-1.08],0.223188119541156,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AMBP,Protein AMBP,Inverse variance weighted,5,1.18 [0.9-1.55],0.22583305513119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,1.21 [0.89-1.63],0.228636297580703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1.12 [0.93-1.34],0.230543157033028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,1.08 [0.95-1.23],0.231698221613337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,1.18 [0.9-1.56],0.233695408820899,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.88 [0.72-1.08],0.234388426871482,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,7,0.85 [0.65-1.11],0.234832540956445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.13 [0.93-1.37],0.235087095045175,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.62 [0.28-1.37],0.235325399095023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1.03 [0.98-1.09],0.236638092172186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.11 [0.93-1.32],0.237540877700929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NRP2,Neuropilin-2,Inverse variance weighted,14,1.13 [0.92-1.37],0.238197189994243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.69 [0.71-4.03],0.238327881176772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDHR1,Cadherin-related family member 1,Inverse variance weighted,19,1.09 [0.94-1.26],0.238585606859187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.17 [0.9-1.52],0.240124074617099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,0.95 [0.87-1.04],0.243667155788474,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL11,Eotaxin,Inverse variance weighted,11,0.93 [0.83-1.05],0.243741340691743,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL19,Interleukin-19,Inverse variance weighted,10,0.94 [0.84-1.04],0.247281319800299,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,XCL1,Lymphotactin,Inverse variance weighted,15,0.88 [0.71-1.09],0.247750511322089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MB,Myoglobin,Inverse variance weighted,9,0.87 [0.68-1.11],0.249258511866564,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,1.42 [0.78-2.56],0.249709166432306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLRF1,Killer cell lectin-like receptor subfamily F member 1,Inverse variance weighted,20,1.1 [0.94-1.28],0.252027895547918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BGLAP,Osteocalcin,Inverse variance weighted,8,0.84 [0.62-1.13],0.252663602811639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD83,CD83 antigen,Inverse variance weighted,14,1.11 [0.93-1.33],0.256403128092713,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,9,1.22 [0.87-1.7],0.256814892779261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,1.1 [0.93-1.31],0.261119215123287,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RSPO1,R-spondin-1,Inverse variance weighted,8,0.87 [0.68-1.11],0.261439972130696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,REN,Renin,Inverse variance weighted,8,0.84 [0.62-1.14],0.262536899839671,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCN4,CCN family member 4,Inverse variance weighted,29,1.05 [0.97-1.13],0.262650571134984,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PALM2,Paralemmin-2,Inverse variance weighted,9,1.08 [0.94-1.25],0.262891296456222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.73 [0.42-1.27],0.26459302828256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,UNC5D,Netrin receptor UNC5D,Wald ratio,1,1.74 [0.65-4.66],0.271822325833728,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,0.97 [0.91-1.03],0.274802790803007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.14 [0.9-1.44],0.274862003923499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.81 [0.56-1.18],0.276599376741621,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.1 [0.92-1.32],0.280709204218547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCGB1A1,Uteroglobin,Inverse variance weighted,38,1.07 [0.95-1.21],0.284344613123175,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,50,0.96 [0.88-1.04],0.286840506966141,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,0.91 [0.76-1.09],0.296151696164618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,0.9 [0.75-1.09],0.297921233266568,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.79 [0.5-1.24],0.299169997328715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AGRP,Agouti-related protein,Inverse variance weighted,16,1.07 [0.94-1.21],0.299565354057955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.03 [0.97-1.1],0.300786801784149,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,0.93 [0.8-1.07],0.303919105497821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.22 [0.83-1.78],0.306149088996905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,11,1.09 [0.92-1.3],0.311467147353172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.19 [0.85-1.67],0.322118456573277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.7 [0.35-1.41],0.322525388742,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.08 [0.93-1.27],0.323425517505002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VWC2,Brorin,Inverse variance weighted,12,1.15 [0.87-1.52],0.323748761741877,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MYL3,Myosin light chain 3,Inverse variance weighted,13,0.88 [0.67-1.14],0.324672498459834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.77 [0.46-1.3],0.325271596694921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SEPTIN8,Septin-8,Inverse variance weighted,4,0.85 [0.61-1.18],0.331314906698934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,0.92 [0.78-1.09],0.331580527210287,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.87 [0.65-1.16],0.332195280877919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD160,CD160 antigen,Inverse variance weighted,24,0.91 [0.75-1.1],0.333867630013278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,OMD,Osteomodulin,Inverse variance weighted,15,1.09 [0.92-1.28],0.334493210207481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,0.88 [0.67-1.15],0.343283281838027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Wald ratio,1,1.54 [0.63-3.81],0.345527848849048,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.92 [0.78-1.09],0.350097763644059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1.11 [0.89-1.39],0.351008945106681,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.89 [0.69-1.14],0.353529894045537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.92 [0.76-1.1],0.354234595323286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.76 [0.42-1.36],0.355968783085554,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.91 [0.75-1.11],0.35869277433184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.29 [0.74-2.23],0.36715253577074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.98 [0.92-1.03],0.367888429795005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.18 [0.82-1.68],0.3702944224057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.86 [0.62-1.19],0.371613210201896,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CTRB1,Chymotrypsinogen B,Inverse variance weighted,19,0.92 [0.78-1.1],0.373170487138691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,6,0.84 [0.57-1.23],0.374670248315576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,POF1B,Protein POF1B,Inverse variance weighted,4,0.87 [0.63-1.19],0.378698687373572,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.92 [0.75-1.11],0.381327510510622,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.23 [0.77-1.96],0.381854823828543,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.91 [0.75-1.12],0.382878303681946,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PENK,Proenkephalin-A,Inverse variance weighted,15,1.07 [0.92-1.26],0.383701037001449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.08 [0.91-1.29],0.389660188288907,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPARCL1,SPARC-like protein 1,Inverse variance weighted,21,0.94 [0.81-1.09],0.390631007893975,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.14 [0.85-1.53],0.394582936751515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.2 [0.79-1.82],0.395549055491269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.98 [0.92-1.03],0.39857867635377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,1.34 [0.68-2.66],0.400292785086305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.13 [0.85-1.5],0.40244521619688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CX3CL1,Fractalkine,Inverse variance weighted,12,0.91 [0.73-1.13],0.403587775435997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.9 [0.71-1.15],0.403918011549614,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,0.94 [0.8-1.09],0.40405461059182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.69 [0.29-1.64],0.405032434143983,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,10,1.09 [0.89-1.35],0.407194802345109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.83 [0.53-1.29],0.407528831544123,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.24 [0.74-2.08],0.409600014793932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VIT,Vitrin,Inverse variance weighted,10,1.09 [0.89-1.33],0.409724971914538,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.05 [0.93-1.19],0.413915661614601,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NRP1,Neuropilin-1,Inverse variance weighted,14,1.09 [0.88-1.35],0.418391144099993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,0.97 [0.89-1.05],0.418883083898749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.07 [0.91-1.26],0.423379949312296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,1.15 [0.82-1.6],0.423963046764845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.91 [0.72-1.15],0.424377502462087,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.1 [0.86-1.41],0.425682982223313,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.79 [0.44-1.42],0.425844884593165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,1.02 [0.97-1.08],0.426266323092294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.21 [0.75-1.95],0.428749466724394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.34 [0.64-2.78],0.43513743056348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.86 [0.59-1.25],0.435437057286804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RGMA,Repulsive guidance molecule A,Inverse variance weighted,35,0.97 [0.88-1.06],0.438142464708938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Inverse variance weighted,16,1.09 [0.88-1.34],0.438794693377619,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,1.1 [0.86-1.42],0.440502079451567,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SDC1,Syndecan-1,Inverse variance weighted,12,0.93 [0.78-1.12],0.44850569117353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.27 [0.69-2.34],0.450496183350438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.79 [0.44-1.45],0.454170023463925,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.85 [0.55-1.31],0.460225327221112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NXPH3,Neurexophilin-3,Inverse variance weighted,19,1.03 [0.95-1.12],0.461707034097559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VASN,Vasorin,Inverse variance weighted,5,0.86 [0.58-1.28],0.463163151104213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,0.89 [0.65-1.22],0.466882657830195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.89 [0.65-1.22],0.470122871159038,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NECTIN4,Nectin-4,Inverse variance weighted,4,0.86 [0.57-1.3],0.472979857888043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.07 [0.89-1.28],0.473222105174634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.18 [0.75-1.84],0.47383869904532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FABP6,Gastrotropin,Inverse variance weighted,4,1.21 [0.72-2.02],0.475985051705567,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.04 [0.93-1.18],0.476326409714828,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.92 [0.74-1.15],0.480731559105237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL15,Interleukin-15,Inverse variance weighted,35,0.96 [0.87-1.07],0.482089627453267,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PCDH17,Protocadherin-17,Inverse variance weighted,44,0.98 [0.91-1.05],0.484867730163137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.11 [0.82-1.51],0.488304697748364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PRELP,Prolargin,Inverse variance weighted,5,0.85 [0.53-1.35],0.488667789419229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.18 [0.74-1.86],0.488720896495053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.85 [0.54-1.34],0.48976961320951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.14 [0.78-1.67],0.495400622082827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SERPINB8,Serpin B8,Inverse variance weighted,29,0.99 [0.95-1.03],0.496554024332426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.22 [0.68-2.21],0.501601531110155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.27 [0.63-2.53],0.502372692027366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.21 [0.69-2.11],0.502409605945678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,1.06 [0.9-1.24],0.510468769266398,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MMP13,Collagenase 3,Wald ratio,1,0.77 [0.35-1.68],0.511643088648523,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PPL,Periplakin,Inverse variance weighted,2,0.85 [0.53-1.37],0.512284001673674,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.1 [0.83-1.47],0.512293030212562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DSG3,Desmoglein-3,Inverse variance weighted,27,1.03 [0.94-1.13],0.512561126200656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.34 [0.56-3.21],0.517141932842131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,1.07 [0.88-1.29],0.517340013864088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.21 [0.68-2.18],0.517388946839796,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,THBD,Thrombomodulin,Inverse variance weighted,11,1.04 [0.92-1.19],0.517669233187414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD27,CD27 antigen,Inverse variance weighted,9,0.87 [0.58-1.32],0.522436388206721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.87 [0.57-1.33],0.522495445416814,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PI3,Elafin,Inverse variance weighted,18,1.03 [0.94-1.14],0.522863162317384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.03 [0.93-1.14],0.52345040834042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,16,0.95 [0.81-1.12],0.526792314016982,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AREG,Amphiregulin,Inverse variance weighted,5,1.11 [0.8-1.53],0.527681827583361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,0.72 [0.27-1.97],0.528586326631632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.89 [0.62-1.28],0.528987292413957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RTBDN,Retbindin,Inverse variance weighted,2,0.86 [0.53-1.38],0.53437526736784,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.95 [0.82-1.11],0.535568954092046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.15 [0.74-1.79],0.536680142431711,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.93 [0.75-1.16],0.537123375953383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.81 [0.41-1.58],0.539567402222502,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,10,0.93 [0.74-1.17],0.545233899267745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,XG,Glycoprotein Xg,Inverse variance weighted,2,0.64 [0.15-2.73],0.549772017811176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,0.92 [0.69-1.22],0.55083901578964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TMPRSS11D,Transmembrane protease serine 11D,Wald ratio,1,1.27 [0.58-2.81],0.552526034334841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MMP7,Matrilysin,Wald ratio,1,0.91 [0.65-1.26],0.55380830027639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,0.98 [0.9-1.06],0.557667911194425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MMP3,Stromelysin-1,Inverse variance weighted,4,0.87 [0.54-1.39],0.559494972443204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.13 [0.75-1.69],0.559753163998293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,0.98 [0.91-1.05],0.561328395415009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.09 [0.82-1.44],0.561554920275205,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,WNT9A,Protein Wnt-9a,Wald ratio,1,1.35 [0.49-3.68],0.561688621795639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,40,0.98 [0.9-1.06],0.562001965762841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,OGN,Mimecan,Inverse variance weighted,37,0.98 [0.9-1.06],0.562863338130349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINK6,Serine protease inhibitor Kazal-type 6,Wald ratio,1,0.78 [0.34-1.81],0.565469926907581,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PCDHB15,Protocadherin beta-15,Inverse variance weighted,19,0.97 [0.87-1.08],0.567764628769465,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,S100G,Protein S100-G,Inverse variance weighted,4,0.9 [0.63-1.29],0.570975938000157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,1.06 [0.86-1.31],0.573221186184752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.06 [0.86-1.3],0.574145870192453,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PREB,Prolactin regulatory element-binding protein,Wald ratio,1,1.28 [0.54-3.07],0.574468987110208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.24 [0.58-2.64],0.576150929603487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1.02 [0.95-1.1],0.57883702000114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.07 [0.85-1.34],0.582351716745994,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.86 [0.5-1.48],0.582804250744355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DPT,Dermatopontin,Inverse variance weighted,4,0.89 [0.57-1.37],0.584679666586436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RSPO3,R-spondin-3,Inverse variance weighted,5,0.91 [0.65-1.28],0.587695515959138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CALB1,Calbindin,Inverse variance weighted,9,1.06 [0.86-1.31],0.589108547626815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,1.4 [0.41-4.8],0.590281509085673,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PGA4,Pepsin A-4,Inverse variance weighted,7,1.08 [0.82-1.42],0.59606412069763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,0.87 [0.52-1.46],0.596563663653727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.89 [0.56-1.39],0.596687027088906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RETN,Resistin,Inverse variance weighted,19,0.95 [0.8-1.14],0.597618131591968,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.97 [0.88-1.08],0.602274105289257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.09 [0.79-1.5],0.607335143524105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CFD,Complement factor D,Wald ratio,1,1.22 [0.57-2.59],0.611079062213149,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPRR3,Small proline-rich protein 3,Inverse variance weighted,6,0.93 [0.68-1.26],0.62360876604132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.05 [0.87-1.25],0.628189084587932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,14,0.94 [0.74-1.2],0.628626064332321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VCAN,Versican core protein,Inverse variance weighted,30,1.03 [0.92-1.15],0.628626239734292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.05 [0.87-1.25],0.629950946958824,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.86 [0.47-1.59],0.63039684413874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.04 [0.87-1.25],0.630619795488434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,13,0.96 [0.81-1.14],0.63326871758422,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.96 [0.81-1.14],0.633499297096834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLK8,Kallikrein-8,Inverse variance weighted,5,0.92 [0.67-1.28],0.636074394261961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,1.02 [0.94-1.11],0.63642666381531,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,0.94 [0.73-1.21],0.638181495475199,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.17 [0.61-2.23],0.639118219404106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,F3,Tissue factor,Inverse variance weighted,13,1.06 [0.82-1.37],0.64189816537121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.92 [0.65-1.31],0.64930279201364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFNB2,Ephrin-B2,Wald ratio,1,0.95 [0.75-1.2],0.650907211102484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.91 [0.61-1.36],0.650998116727876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,17,0.97 [0.84-1.11],0.653094413108179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.01 [0.95-1.08],0.653173086423383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPON1,Spondin-1,Inverse variance weighted,4,1.16 [0.61-2.21],0.655603024933466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FAM3D,Protein FAM3D,Inverse variance weighted,38,0.98 [0.9-1.07],0.657213087230554,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.03 [0.89-1.19],0.658684297524697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GP1BA,Platelet glycoprotein Ib alpha chain,Inverse variance weighted,24,0.96 [0.81-1.14],0.659008944369281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PRSS2,Trypsin-2,Inverse variance weighted,17,1.03 [0.9-1.19],0.663287063749137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.02 [0.94-1.1],0.66342608394081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.05 [0.85-1.29],0.667487599007059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.13 [0.64-2.01],0.674150020724268,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.06 [0.8-1.42],0.674418362937411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.96 [0.8-1.16],0.680305568893518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.97 [0.82-1.14],0.684147085563477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.99 [0.94-1.04],0.684636895160951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.95 [0.73-1.23],0.685838421976207,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.93 [0.65-1.33],0.685938491133513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.95 [0.74-1.22],0.689233537805179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CFC1,Cryptic protein,Inverse variance weighted,11,1.07 [0.78-1.45],0.69029632856009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.93 [0.67-1.31],0.691746410007561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.06 [0.81-1.38],0.691801710466536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PRSS8,Prostasin,Inverse variance weighted,14,1.04 [0.85-1.28],0.695794891569262,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.1 [0.69-1.75],0.699795377226027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,1.1 [0.68-1.8],0.7002636617263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.11 [0.66-1.85],0.702059680988585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.04 [0.86-1.25],0.705199685783222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ALCAM,CD166 antigen,Inverse variance weighted,4,0.94 [0.7-1.27],0.70749695154381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ANG,Angiogenin,Inverse variance weighted,8,0.92 [0.6-1.42],0.710444726875011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,0.88 [0.46-1.7],0.711176432632169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHGB,Secretogranin-1,Inverse variance weighted,7,0.96 [0.78-1.19],0.715587129434175,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.97 [0.84-1.13],0.71829175689499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,1.05 [0.8-1.37],0.718545111944125,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.04 [0.84-1.29],0.720570158715247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.01 [0.95-1.08],0.72370001802292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.09 [0.67-1.78],0.723828463670841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,OCLN,Occludin,Inverse variance weighted,2,0.91 [0.55-1.51],0.725370137435991,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.96 [0.75-1.22],0.730266607176606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.96 [0.77-1.2],0.734510237178137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,1.03 [0.85-1.26],0.735128677634721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.96 [0.77-1.2],0.735410752594184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,0.98 [0.9-1.08],0.740892029967434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.93 [0.6-1.43],0.745410994183388,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.05 [0.8-1.37],0.74609840031923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.06 [0.74-1.52],0.746622070891805,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LGALS3,Galectin-3,Inverse variance weighted,15,1.04 [0.84-1.28],0.746624645968767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CTSL,Cathepsin L1,Inverse variance weighted,29,0.98 [0.86-1.12],0.748311416845353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPON2,Spondin-2,Inverse variance weighted,3,1.08 [0.67-1.75],0.760380386542207,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,38,1.01 [0.93-1.11],0.763178205432197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.94 [0.64-1.39],0.766109157886067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,10,0.96 [0.73-1.26],0.767513049046891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.92 [0.54-1.57],0.767893981478414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.11 [0.56-2.19],0.770261389199963,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.03 [0.84-1.27],0.771706075715971,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PLA2G1B,Phospholipase A2,Inverse variance weighted,20,1.02 [0.88-1.19],0.773626113727224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1.02 [0.9-1.15],0.77463629415899,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.93 [0.57-1.53],0.77951646034364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.09 [0.61-1.95],0.779530638624624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GRN,Progranulin,Inverse variance weighted,46,1.01 [0.95-1.07],0.783034052994403,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.03 [0.84-1.25],0.784228689132819,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.95 [0.65-1.38],0.787307790458216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.08 [0.63-1.86],0.788022025313902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDH15,Cadherin-15,Inverse variance weighted,4,0.94 [0.61-1.46],0.788345889169221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.07 [0.64-1.81],0.790116247743661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,1.02 [0.91-1.14],0.794775599908433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BSG,Basigin,Inverse variance weighted,6,0.96 [0.69-1.33],0.796079335325227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LAYN,Layilin,Inverse variance weighted,3,0.93 [0.55-1.58],0.79779947247689,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.02 [0.9-1.15],0.802701936057067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTPRR,Receptor-type tyrosine-protein phosphatase R,Wald ratio,1,0.93 [0.54-1.61],0.802914763631459,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,0.95 [0.62-1.44],0.805654027785416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,1.05 [0.73-1.5],0.808171839284239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.01 [0.93-1.09],0.808630368496338,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.05 [0.72-1.54],0.809186701525269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CTSV,Cathepsin L2,Inverse variance weighted,34,1.01 [0.92-1.12],0.809448117998518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.99 [0.89-1.1],0.812224268756855,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Wald ratio,1,1.11 [0.48-2.53],0.812482887397348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,0.99 [0.92-1.07],0.817102766743995,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.03 [0.78-1.36],0.817844076290868,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.01 [0.9-1.15],0.818829646500018,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.94 [0.55-1.6],0.818889626063167,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.03 [0.78-1.37],0.819413876013918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,6,1.04 [0.73-1.48],0.819435142109834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,0.98 [0.83-1.15],0.820909209021155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,0.97 [0.77-1.23],0.823336144500414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,APOA4,Apolipoprotein A-IV,Inverse variance weighted,4,0.95 [0.61-1.49],0.827083467578025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.02 [0.83-1.26],0.82821886065157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.96 [0.63-1.45],0.830630132879929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLK4,Kallikrein-4,Inverse variance weighted,5,1.05 [0.67-1.65],0.830766672533584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.93 [0.5-1.74],0.832707855987067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.06 [0.63-1.77],0.835778939726119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLK11,Kallikrein-11,Inverse variance weighted,13,0.98 [0.82-1.17],0.83587251601139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CALCA,Calcitonin,Inverse variance weighted,13,1.03 [0.78-1.36],0.847022464808551,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.98 [0.78-1.23],0.848118892824223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.02 [0.82-1.28],0.849488087135917,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PALM,Paralemmin-1,Inverse variance weighted,4,0.95 [0.58-1.57],0.850383655550842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.97 [0.72-1.32],0.850988183740924,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,1.04 [0.72-1.5],0.852082645310192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHAD,Chondroadherin,Inverse variance weighted,15,0.99 [0.89-1.1],0.85831519596656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.02 [0.82-1.26],0.860981757145038,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.93 [0.42-2.05],0.861437291479671,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.99 [0.85-1.15],0.863697698238913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.02 [0.82-1.27],0.86383150066702,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDH3,Cadherin-3,Inverse variance weighted,10,1.03 [0.75-1.4],0.871658559861013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,1.04 [0.6-1.81],0.875604239216681,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,9,1.01 [0.87-1.17],0.875776812956381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DSC2,Desmocollin-2,Inverse variance weighted,16,0.99 [0.89-1.1],0.876288582509256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,43,1 [0.95-1.05],0.877102265074613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.99 [0.9-1.09],0.878759889589105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Wald ratio,1,1.04 [0.6-1.81],0.880518723508015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCG2,Secretogranin-2,Inverse variance weighted,2,0.97 [0.62-1.52],0.881238976962954,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1 [0.96-1.04],0.884014248566155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,1.02 [0.82-1.27],0.884777231093518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.99 [0.82-1.19],0.886287301173667,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1 [0.95-1.05],0.887092320495521,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.98 [0.76-1.27],0.890195908487204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.01 [0.83-1.23],0.893746788637095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,1 [0.93-1.06],0.897617501160438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPP1,Osteopontin,Inverse variance weighted,13,0.98 [0.75-1.29],0.897658307561021,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,0.98 [0.68-1.4],0.898721394848028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.98 [0.74-1.31],0.89971930479974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.02 [0.75-1.38],0.903632804477326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL17C,Interleukin-17C,Inverse variance weighted,5,0.98 [0.69-1.39],0.907511404796182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NECTIN2,Nectin-2,Inverse variance weighted,3,0.96 [0.44-2.08],0.918782858919326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DSG2,Desmoglein-2,Inverse variance weighted,22,0.99 [0.89-1.11],0.920012698604088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.96 [0.42-2.18],0.923019721047661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.01 [0.89-1.14],0.923359824352018,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.99 [0.86-1.14],0.923895494733739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LGALS4,Galectin-4,Inverse variance weighted,15,1.01 [0.9-1.13],0.929323635624825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,19,1 [0.93-1.09],0.935003783222411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.98 [0.63-1.53],0.935301350104042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DCN,Decorin,Inverse variance weighted,2,1.03 [0.55-1.91],0.937329024868741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,2,1.02 [0.58-1.8],0.938188876293845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,1.01 [0.87-1.16],0.940091046674904,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,COLEC12,Collectin-12,Inverse variance weighted,3,1.02 [0.62-1.68],0.940990132818111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.02 [0.6-1.74],0.943988330097676,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.01 [0.85-1.19],0.945506826877771,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,1.01 [0.8-1.27],0.947972179761244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GHRL,Appetite-regulating hormone,Inverse variance weighted,14,1.01 [0.76-1.34],0.949034021082746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,1.01 [0.59-1.76],0.95786159972104,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.01 [0.75-1.34],0.95901324353211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,0.98 [0.45-2.13],0.962039909849801,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1 [0.89-1.11],0.963305490511845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCN5,CCN family member 5,Inverse variance weighted,12,1 [0.89-1.13],0.965546822587111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GUCA2A,Guanylin,Inverse variance weighted,7,0.99 [0.78-1.26],0.966339602505235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.01 [0.5-2.04],0.967707909853206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCN3,CCN family member 3,Inverse variance weighted,17,1 [0.89-1.12],0.968216959073225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.99 [0.57-1.71],0.974426082813791,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,0.99 [0.69-1.44],0.975699660272974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDH1,Cadherin-1,Inverse variance weighted,16,1 [0.89-1.12],0.983578027232234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CSTB,Cystatin-B,Inverse variance weighted,23,1 [0.93-1.08],0.986807079574923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1 [0.83-1.2],0.987172092105085,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHGA,Chromogranin-A,Inverse variance weighted,5,1 [0.72-1.39],0.994432520183541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1 [0.79-1.27],0.995275730459338,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1 [0.78-1.29],0.995645033973629,trans
